| Associate Submission Manager |
Hyderabad (Office) |
India |
Biomedical Research |
|
Research & Development |
12 Augustus 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
India |
Biomedical Research |
|
Research & Development |
12 Augustus 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
India |
Biomedical Research |
|
Research & Development |
12 Augustus 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
India |
Biomedical Research |
|
Research & Development |
12 Augustus 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
India |
Biomedical Research |
|
Research & Development |
12 Augustus 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
India |
Biomedical Research |
|
Research & Development |
12 Augustus 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 Mei 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 Mei 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 Mei 2024 |
| Procure to Pay Senior Specialist MR11 |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
23 Juli 2024 |
| Order to Cash Radioligand Therapy Sr. Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
06 Augustus 2024 |
| LDC Adopt Process Lead - Taxes |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
19 Augustus 2024 |
| TCM Senior Cash Management Specialist |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
30 Augustus 2024 |
| Record to Report Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
05 September 2024 |
| Record to Report Sr Specialist |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Record to Report Sr Specialist Intercompany |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Record to Report Sr Specialist US |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Fixed Assets Sr Specialist |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Buyer LACan (Temporary) |
INSURGENTES |
Mexico |
Operations |
CTS |
Procurement |
15 September 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 Mei 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
22 Oktober 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 Mei 2024 |
| Treasury Manager |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
20 Juni 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
17 Juli 2024 |
| Order Management Specialist - Temporary |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
25 September 2024 |
| P2P Process Excellence |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
02 Oktober 2024 |
| Global FC&C Process Expert (Senior Manager) PIN-PCA |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
03 Oktober 2024 |
| P2P Service Delivery (SD) Lead NGSC |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
07 Oktober 2024 |
| Finance Control and Compliance US Manager |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
08 Oktober 2024 |
| General Accounting Manager |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
09 Oktober 2024 |
| Coordinator, Global Program Management and Portfolio Excellence |
INSURGENTES |
Mexico |
Biomedical Research |
CTS |
Research & Development |
15 Oktober 2024 |
| Procure to Pay Business Partner Management |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
16 Oktober 2024 |
| Procure to Pay Business Partner US Temporary |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
22 Oktober 2024 |
| Business Planning Analysis Manager / Analyst |
INSURGENTES |
Mexico |
Biomedical Research |
CTS |
Audit & Finance |
23 Oktober 2024 |
| Chef, Communications corporatives |
Montreal |
Canada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
21 Oktober 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 Mei 2024 |
| IT Strategic Business Partner US&I (Salesforce) |
Barcelona Gran Vía |
Spain |
Operations |
CTS |
Technology Transformation |
01 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
24 September 2024 |
| 县域主任(主管) |
Luoyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
26 September 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
29 September 2024 |
| Therapy Area Partner |
Abha |
Saudi Arabia |
International |
Innovative Medicines |
Sales |
01 Oktober 2024 |
| Ingénieur Biotech Culture Cellulaire / USP (H/F) |
Huningue |
France |
Operations |
Innovative Medicines |
Technical Operations |
02 Oktober 2024 |
| RWE Lead H/F CDD 12 mois |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Research & Development |
04 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
09 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
09 Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09 Oktober 2024 |
| Head, Clinical Development Business Solutions |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
10 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
10 Oktober 2024 |
| Expert Développement des Compétences - Visite Médicale H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Sales |
11 Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
11 Oktober 2024 |